Asymmetric Arginine dimethylation of Epstein–Barr virus nuclear antigen 2 promotes DNA targeting

Abstract The Epstein–Barr virus (EBV) growth-transforms B-lymphocytes. The virus-encoded nuclear antigen 2 (EBNA2) is essential for transformation and activates gene expression by association with DNA-bound transcription factors such as RBPJκ (CSL/CBF1). We have previously shown that EBNA2 contains...

Full description

Saved in:
Bibliographic Details
Published inVirology (New York, N.Y.) Vol. 397; no. 2; pp. 299 - 310
Main Authors Gross, Henrik, Barth, Stephanie, Palermo, Richard D, Mamiani, Alfredo, Hennard, Christine, Zimber-Strobl, Ursula, West, Michelle J, Kremmer, Elisabeth, Grässer, Friedrich A
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 20.02.2010
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract The Epstein–Barr virus (EBV) growth-transforms B-lymphocytes. The virus-encoded nuclear antigen 2 (EBNA2) is essential for transformation and activates gene expression by association with DNA-bound transcription factors such as RBPJκ (CSL/CBF1). We have previously shown that EBNA2 contains symmetrically dimethylated Arginine (sDMA) residues. Deletion of the RG-repeat results in a reduced ability of the virus to immortalise B-cells. We now show that the RG repeat also contains asymmetrically dimethylated Arginines (aDMA) but neither non-methylated (NMA) Arginines nor citrulline residues. We demonstrate that only aDMA-containing EBNA2 is found in a complex with DNA-bound RBPJκ in vitro and preferentially associates with the EBNA2-responsive EBV C, LMP1 and LMP2A promoters in vivo . Inhibition of methylation in EBV-infected cells results in reduced expression of the EBNA2-regulated viral gene LMP1, providing additional evidence that methylation is a prerequisite for DNA-binding by EBNA2 via association with the transcription factor RBPJκ.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0042-6822
1096-0341
DOI:10.1016/j.virol.2009.11.023